Four German Centers to Buy Next-Gen Sequencers From Roche, Solexa, ABI; Solexa's GAS In Place at Max Planck

The purchases, worth $6 million, are aimed at helping Germany "make a very bold move towards ultra-high-throughput sequencing in order to strengthen its scientific portfolio in genetic epidemiology and systematic functional exploration of complex diseases."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.